In addition to WHO grade, it is acknowledged that IDH mutation, chromosome 1p19q codeletion, MGMT promoter methylation status, and transcriptome subtypes play a vital role in glioma progression [30, 31]. Here, MGMT is linked to central nervous system cancer.